These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7729501)

  • 1. Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.
    Won SJ; Chuang YC; Huang WT; Liu HS; Lin MT
    Experientia; 1995 Apr; 51(4):343-8. PubMed ID: 7729501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell cytotoxicity: role of calmodulin.
    Rochette-Egly C; Tovey MG
    Biochem Biophys Res Commun; 1984 Jun; 121(2):478-86. PubMed ID: 6203532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.
    Dwyer DS; Liu Y; Bradley RJ
    Neurosci Lett; 1999 Oct; 274(3):151-4. PubMed ID: 10548412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
    Saurer TB; Carrigan KA; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of catecholamines in recall of the conditioned NK cell response.
    Hsueh CM; Kuo JS; Chen SF; Huang HJ; Cheng FC; Chung LJ; Lin RJ
    J Neuroimmunol; 1999 Feb; 94(1-2):172-81. PubMed ID: 10376951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ
    Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of phenothiazines on NK-mediated cytolysis of tumor cells.
    Laing LP; Boegman RJ; Roder JC
    Immunopharmacology; 1984 Aug; 8(1):1-12. PubMed ID: 6490356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
    Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
    Katz JL; Kopajtic TA; Terry P
    Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens.
    Furukawa T; Morishita H
    Eur J Pharmacol; 1997 Jun; 328(2-3):229-34. PubMed ID: 9218705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal stresses reduce natural killer cell cytotoxicity.
    Won SJ; Lin MT
    J Appl Physiol (1985); 1995 Sep; 79(3):732-7. PubMed ID: 8567511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of catecholamines with alpha-methyl-p-tyrosine suppresses splenic NK cell activity.
    Won SJ; Lin MT
    Int J Immunopharmacol; 1989; 11(5):451-7. PubMed ID: 2807623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
    Samochowiec J; Kleinrok Z; Jagiełło-Wójtowicz E; Horodnicki J; Rommelspacher H; Schmidt LG
    Pol J Pharmacol; 1997 Aug; 49(4):221-7. PubMed ID: 9437765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dopaminergic agents on cell-mediated immune response in mice.
    Panajotova V
    Physiol Res; 1997; 46(2):113-8. PubMed ID: 9727502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.